Keywords: bi, viramune, shows, efficacy, advanced, hiv, boehringer
BI's Viramune shows efficacy in advanced HIV
Article | 03 February 2000
Boehringer Ingelheim's Viramune (nevirapine), when combined with GlaxoWellcome's Epivir (lamivudine) and Retrovir (zidovudine), suppressed HIV-RNA in the blood for up ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
